Caricamento...
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
OBJECTIVE: This study used a decision-analytic framework to assess the cost-effectiveness of brexpiprazole vs comparator branded therapies for reducing relapses and hospitalizations among adults with schizophrenia from a US payer perspective. METHODS: An economic model was developed to assess patien...
Salvato in:
| Pubblicato in: | Clinicoecon Outcomes Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101022/ https://ncbi.nlm.nih.gov/pubmed/30147350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S160252 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|